Extracorporeal Membrane Oxygenation Machine Market Estimates & Strategy Framework To 2022 - 2030.

The global extracorporeal membrane oxygenation machine market size is expected to reach USD 445.7 million by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 5.3% during the forecast period. The market is primarily driven by the increasing incidence of cardiopulmonary & respiratory diseases and technological advancements in the field of ECMO procedures. Cardiovascular disease is one of the leading causes of death globally.

Extracorporeal Membrane Oxygenation Machine Market Segmentation

Grand View Research has segmented the global ECMO machine market based on component, modality, patient type, and application:

Based on the Component Insight, the market is segmented into Pumps, Oxygenator, Controllers, Cannula and Accessories.

• The oxygenators segment accounted for the largest market revenue share of 34.2% in 2021 and is expected to grow at a lucrative rate during the forecast period.
• The pumps segment also has considerable market share owing to high cost and usage. The pumps in ECMO machines help pump blood from a patient to artificial lungs that send the blood back to the patient after oxygenation.
• The growth of the segment is primarily attributed to its high usage of pumps in ECMO procedures and the availability of various types of pumps such as roller, impeller, and centrifugal.

Based on the Modality Insight, the market is segmented into Veno-Arterial, Veno-Venous and Arterio-Venous.

• The veno-arterial segment accounted for the largest market revenue share of 41.8% in 2021 and is expected to grow at a healthy CAGR during the forecast period.
• Veno-venous segment captured a significant share in 2021 and is expected to grow at a lucrative growth rate during the forecast period.
• The key drivers of the ECMO machine market are the increasing incidence of chronic obstructive pulmonary disease.

Based on the Patient Type Insight, the market is segmented into Tablets, Capsules, Powder, Softgels, Liquid and Gummies.

• The adult patient segment accounted for the largest market revenue share of 59.0% in 2021 and is also expected to grow at the fastest rate during the forecast period.
• Consumption of alcohol, tobacco, and smoking coupled with a sedentary lifestyle are increasing the global burden of cardiac and respiratory diseases in adults.
• The pediatric segment also accounted for a considerable market share and is expected to grow at a robust pace during the forecast period.

Based on the Application Insight, the market is segmented into Respiratory, Cardiac and ECPR.

• The respiratory segment accounted for the largest market share of 44.0% in 2021. The key market drivers include the increasing prevalence of respiratory disorders and rising awareness of ECMO procedures.
• The cardiac surgery segment also accounted for a considerable market share in 2021 owing to the increasing incidence of cardiac surgery and rising awareness about ECMO machines in cardiac surgery.
• According to a study, the total direct medical costs of cardiovascular diseases are expected to reach USD 749 million by 2035.

Extracorporeal Membrane Oxygenation Machine Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Terumo Cardiovascular Systems Corporation launched CAPIOX FX advance oxygenator. This device comprises advanced features, such as increased blood flow rate with a 3,000 ml reservoir and enhanced flow dynamics. Thus, such launches deliver better performance and support market growth.

Some prominent players in the Global Extracorporeal Membrane Oxygenation Machine market include:

• Medtronic plc
• Sorin Group
• Terumo Cardiovascular Systems Corporation
• MAQUET Holding B.V. & Co. KG
• Medos Medizintechnik AG
• Nipro Medical Corporation
• Microport Scientific Corporation

Order a free sample PDF of the in Extracorporeal Membrane Oxygenation Machine Market Intelligence Study, published by Grand View Research.